Clinical Trial Update: Effect of Cyproheptadine on Ventilatory Support-free Days in Critically Ill Patients With COVID-19 [Phase 3]

View source ↗

Summary

Phase 3 trial investigating whether cyproheptadine affects ventilatory support-free days in critically ill COVID-19 pneumonia patients; current status is unknow…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• COVID-19 Pneumonia

Drugs mentioned

• Cyproheptadine (cyproheptadine)

Snippet

Sponsor: Hospital de Clinicas de Porto Alegre | Conditions: COVID-19 Pneumonia | Phase 3 | Status: UNKNOWN